Unique ID issued by UMIN | UMIN000043164 |
---|---|
Receipt number | R000049262 |
Scientific Title | Levetiracetam pharmacokinetics analysis and elucidation of appropriate administration design in critically ill patients |
Date of disclosure of the study information | 2021/01/29 |
Last modified on | 2021/01/28 13:52:37 |
Levetiracetam pharmacokinetics analysis and elucidation of appropriate administration design in critically ill patients
Levetiracetam pharmacokinetics analysis and elucidation of appropriate administration design in critically ill patients
Levetiracetam pharmacokinetics analysis and elucidation of appropriate administration design in critically ill patients
Levetiracetam pharmacokinetics analysis and elucidation of appropriate administration design in critically ill patients
Japan |
Severely ill patients requiring administration of antiepileptics drugs
Intensive care medicine |
Others
NO
Pharmacokinetics of levetiracetam by renal function and CRRT in critically ill patients ,elucidation of changes and establishment of appropriate administration design
Efficacy
Comparison of Levetiracetam pharmacokinetics by renal function
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Other |
Immediately before the end of the infusion on the day when levetiracetam is administered, and 0.5,1,2,4,8and12 hours after the end of the infusion,a total of 7 blood samples and dialysis filtrate are collected.
A single blood sampling volume of about 3ml is required.
Immediately before the end of the infusion on the day when levetiracetam is administered, and 0.5,1,2,4,8and12 hours after the end of the infusion,a total of 7 blood samples are collected.
A single blood sampling volume of about 3ml is required.
20 | years-old | <= |
Not applicable |
Male and Female
1)Inpatients receiving levetiracetam in the ICU
2)Patients over 20 years old
3)Patients whose consent has been obtained in writing by the person or his / her substitute
1) When an adverse event occurs
2)When the underlying disease worsens and the doctor in charge decides that it should be the center
3)A serious violation of the research implementation plan was found.
4)The subject canceled the research participation.
5)The subject's cooperation could not be obtained.
30
1st name | Shinichi |
Middle name | |
Last name | Nishi |
Hyogo College of Medicine
Intensive Care Unit
663-8501
1-1,Mukogawa-cho,Nishinomiya-city,Hyogo,Japan
0798-45-6389
shinitch@gmail.com
1st name | mana |
Middle name | |
Last name | taguchi |
Hyogo College of Medicine
Intensive Care Unit
663-8501
1-1,Mukogawa-cho,Nishinomiya-city,Hyogo,Japan
0798-45-6389
bbbsc333mana@gmail.com
Hyogo College of Medicine
Hyogo College of Medicine
Self funding
Hyogo College of Medicine
1-1,Mukogawa-cho,Nishinomiya-city,Hyogo,Japan
0798-45-6389
rinri@hyo-med.ac.jp
NO
2021 | Year | 01 | Month | 29 | Day |
Unpublished
Enrolling by invitation
2021 | Year | 01 | Month | 31 | Day |
2021 | Year | 08 | Month | 01 | Day |
2021 | Year | 04 | Month | 01 | Day |
2021 | Year | 12 | Month | 31 | Day |
2021 | Year | 01 | Month | 28 | Day |
2021 | Year | 01 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049262
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |